Summary
Chromosomes from leukocyte cultures and direct bone marrow preparations from patients under Azathioprine treatment were examined and compared with those from uremic patients and normal controls not taking Azathioprine. The results indicate a toxic effect of the drug, as well as an effect of uremia on the chromosome complement. The significance of these findings is discussed, especially in relation to several reports concerning malignant processes arising during or after Azathioprine intake. According to our findings, a relation between immunosuppression and malignancy seems more likely than a direct cancerogenicity of Azathioprine.
Zusammenfassung
Chromosomen aus peripherem Blut und direkten Knochenmarkspräparaten von Patienten unter Azathioprin-Therapie wurden verglichen mit solchen von gesunden Kontrollpersonen und urämischen Patienten ohne Azathioprin-Einnahme. Die Ergebnisse sprechen für eine toxische Chromosomenschädigung sowohl durch Azathioprin als auch die urämische Stoffwechsellage. Die Bedeutung dieser Befunde, insbesondere im Zusammenhang mit mehrfach berichteten malignen Prozessen nach Azathioprin-Einnahme, wird diskutiert. Unsere Ergebnisse lassen eher einen Zusammenhang zwischen Immunosuppression und malignem Geschehen vermuten als eine direkte cancerogen Wirkung von Azathioprin.
Similar content being viewed by others
References
Annotations: Chromosome breakage and leukaemia. Lancet 1967I, 36.
Bloom, G. E., Warner, S., Gerald, P. S., Diamond, L. K.: Chromosome abnormalities in constitutional aplastic anaemia. New Engl. J. Med. 274, 8–14 (1966)
Cavalli-Sforza, L.: Grundbegriffe der Biometrie. Stuttgart: Fischer 1964
Doak, P. B., Montgomerie, J. Z., North, J. D. K., Smith, F.: Reticulum cell sarcoma after renal homotransplantation and azathioprine and prednisolone therapy. Brit. med. J. 1968 IV, 746–748.
Eberle, P., Hunstein, W., Perings, E.: Chromosomes in patients treated with imuran. Humangenetik 6, 69–73 (1968).
Friedrich, U., Zeuthen, E.: Chromosomenabnormitäten und Behandlung mit Imuran® (Azathioprin) nach Nierentransplantationen. Humangenetik 8, 289–294 (1970).
Gabrielsen, A. E., Cooper, M. D., Peterson, R. D. A., Good, R. A.: The primary immunologic deficiency disease. Textbook of immunopathology, P. A. Miescher, H.-J. Müller-Eberhard (eds.), Vol. II, pp. 385–405. New York: Grune & Stratton 1968.
German, J., Pugliatti Crippa, L.: Chromosome breakage in diploid cell lines from Bloom's syndrome and Fanconi's anaemia. Ann. Génét. 9, 143–154 (1966).
Gropp, A., Flatz, G.: Chromosome breakage and blastic transformation of lymphocytes in ataxia teleangiectasia. Humangenetik 5, 77–79 (1967).
Hampel, K. E., Kober, B., Rösch, D., Gerhartz, H., Meinig, K. H.: The action of cytostatic agents on the chromosomes of human leucocytes in vitro. Blood 27, 816–823 (1966).
Hungerford, D. A.: Leucocytes cultured from small inocula of whole blood and preparation of metaphase chromosomes by treatment with hypotonic KCl. Stain Technol. 40, 333–338 (1965).
Kim, H.-H., Williams, T. J.: Endometrioid carcinoma of the uterus and ovaries associated with immunosuppressive therapy and anticoagulation. Mayo Clin. Proc. 47 39–41 (1972).
Krogh Jensen, M.: Chromosomes studies in patients treated with azathioprine and amethopterin. Acta med. scand. 182, 445–455 (1967).
Krogh Jensen, M.: Effect of azathioprine on the chromosome complement of human bone-marrow cells. Int. J. Cancer 5, 147–151 (1970).
Krogh Jensen, M., Søborg, M.: Chromosome aberrations in human cells following treatment with imuran. Preliminary report. Acta med. scand. 179, 249–250 (1966).
Leb, D. E., Weißkopf, B., Kanovitz, B. S.: Chromosome aberrations in the child of a kidney transplant recipient. Arch. intern. Med. 128, 441–444 (1971).
Lower, G. D., Stevens, L. E., Najarian, J. S., Reemtsma, K.: Problems from immunosuppression during pregnancy. Amer. J. Obstet. Gynec. 111, 1120–1121 (1971).
Marsch, W., Niederalt, G., Gropp, A.: Chromosomenanomalien nach Strahlenbelastung. Dtsch. med. Wschr. 90, 2205–2208 (1965).
Mella, B.: Chromosomal damage associated with infectious hepatitis and its possible teratogenic significance. Neurology (Minneap.) 8, 741–744 (1968).
Sharpstone, P., Ogg, C. S., Cameron, J. S.: Nephrotic syndrome due to primary renal disease in adults: a controlled trial of prednisolone and azathioprine. Brit. med. J. 1969 II, 535–539.
Swanson, M. A., Schwartz, R. S.: Immunosuppressive therapy. New Engl. J. Med. 277, 163–170 (1967).
Tijo, J. H., Whang, J.: Chromosome preparation of bone-marrow cells without prior in vitro or in vivo colchicine administration. Stain Technol. 37, 17–20 (1962).
Willoughby, J. M. T., Kumar, P. J. Beckett, J., Dawson, A. M.: Controlled trial of azathioprine in Crohn's disease. Lancet 1971 II, 944–947.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ganner, E., Osment, J., Dittrich, P. et al. Chromosomes in patients treated with Azathioprine. Hum Genet 18, 231–236 (1973). https://doi.org/10.1007/BF00290602
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00290602